Contact details
Alexander Stahmann kontakt@msregister.de
Main
Publications
Data source publications
- Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry. Frahm N, Fneish F, Ellenberger D, et al., 2022: Neurology and Therapy article published online: 12 January 2022, doi:10.1007/s40120-021-00320-w
- Aggressive multiple sclerosis – a matter of measurement and timing. Ellenberger D, Flachenecker P, Fneish F, Frahm N,Hellwig K, Paul F, Stahmann A, Warnke C, Rommer PS, Zettl UK, 2020: BRAIN published online: September 2020, doi:10.1093/brain/awaa306
- Prevalence of pediatric multiple sclerosis in Germany - a nationwide population -based analysis of outpatient insurance claims. Frahm N, Peters M, Bätzing J, Ellenberger D, Akmatov MK, Haas J, Rommer PS, Stahmann A, Zettl UK, Holstiege J, 2021: European Journal of Neurology Vol 28, Issue 9, p3173-3176, first published online: July 9, 2021, doi:10.1111/ene.15015
- Treatment patterns in pediatric patients with multiple sclerosis in Germany - a nationwide claims-based analysis. Frahm N, Peters M, Bätzing J, Ellenberger D, Akmatov MK, Haas J, Rommer PS, Stahmann A, Zettl UK, Holstiege J, 2021: Therapeutic Advances in Neurological Disorders published online: October 6, 2021, doi:10.1177/17562864211048336
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. Simpson-Yap S, Stahmann A, et al., 2021: Neurology Article first published online: October 5, 2021, doi:10.1212/WNL.0000000000012753